Advertisement

Topics

Latest "ESBE Scientific" News Stories

20:24 EDT 17th October 2018 | BioPortfolio

Here are the most relevant search results for "ESBE Scientific" found in our extensive news archives from over 250 global news sources.

More Information about ESBE Scientific on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about ESBE Scientific for you to read. Along with our medical data and news we also list ESBE Scientific Clinical Trials, which are updated daily. BioPortfolio also has a large database of ESBE Scientific Companies for you to search.

Showing "ESBE Scientific" News Articles 1–25 of 3,900+

Wednesday 17th October 2018

Global Urological Catheters Market Status and Outlook 20182025 [Report Updated: 15082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynamics Regulations and Global Market OverviewPart 2:Upstream Raw Materials / Components Manufacturing Procurement Methods Channels and Cost , Major Regional Production Overview and Trade FlowPart 3:Pr...


Eurobio Scientific SA ALEHT Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 11102018] Prices from USD $250

SummaryEurobio Scientific SA Eurobio, formerly Diaxonhit SA, a subsidiary of Hellenic Petroleum SA, is a biotechnology company that provides diagnostic products. The company provides products such as TQS, which is used in treatment of teanus and BJI InoPlex, used for the treatment of prosthetic infection. It develops other diagnostic products using its molecular biology platform such as Dx15, a mo...

Tinder For Cheetahs; and An Unusual Blindness

Scientific American assistant news editor Tanya Lewis and collections editor Andrea Gawrylewski host a new podcast that takes an deeper look at short articles from the Advances news section of the... -- Read more on ScientificAmerican.com


In Boston, Paul Allen Aimed to Boost Bioscience’s “Tempo of Discovery”

The scientific interests of the late Microsoft co-founder Paul Allen led him to fund a pair of major research centers in the Boston area devoted to cracking mysteries of the human biological code—and aiming to recreate the sort of foundational work he and Bill Gates applied to personal computing in the 1970s. Allen—who died Monday […]

A stable & sustainable workforce is crucial to @US_FDA’s success in keeping pace with scientific advances in biopharma drug development and ensuring safe and effective innovative medicines reach patients quickly. Learn more. https://onphr.ma/2Co1Wgy 

A stable & sustainable workforce is crucial to @US_FDA’s success in keeping pace with scientific advances in biopharma drug development and ensuring safe and effective innovative medicines reach patients quickly. Learn more. https://onphr.ma/2Co1Wgy 

Immune-Onc Therapeutics and University of Texas Report a Novel Target for Acute Myeloid Leukemia in Nature

Immune-Onc Therapeutics, Inc. (“Immune-Onc”), a privately held cancer immunotherapy company dedicated to the discovery and development of novel biologic treatments for cancer patients, announced today the publication of a study in Nature (DOI: 10.1038/s41586-018-0615-z) that provi

VALBIOTIS confirms its interest in the study of the intestinal microbiota, a promising field in the prevention of metabolic diseases

VALBIOTIS develops leading expertise in this field of research VALBIOTIS compiles a base of human data in the field of metabolic diseases, with high value potential VALBIOTIS focuses on the French population's understanding of the intestinal microbiota through an unprecedented Opinéa survey Regulatory ...

Dr. Dan Holtzclaw Develops and Publishes Minimally Invasive Technique for the Treatment of Iatrogenic Nerve Injuries Secondary to Dental Implant Treatment

Dr. Dan Holtzclaw utilizes 13 years of experience in placental allograft research to develop new technique for the treatment of nerve injuries secondary to the placement of dental implants. AUSTIN, Texas (PRWEB) October 17, 2018 Dr. Dan Holtzclaw, Chief Clinical Officer of DIA Dental Implant Centers, has recently published a new technique documenting the use of placental based growth factors for ...

Slone Partners, Where People Are Our Science®, Announces Insights: Scientific Healthcare Investing 2018 Panel Event With Leaders In The Investment Community

Produced in conjunction with Biocom, the October 25, 2018 discussion in South San Francisco explores the capital markets and conditions driving innovative companies forward in Drug Discovery, Services, Tools and Diagnostics. SAN FRANCISCO (PRWEB) October 17, 2018 Slone Partners, the leading executive search firm for life sciences, diagnostics, and scientific healthcare companies, proudly announce...

Takara Bio Inc 4974 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12102018] Prices from USD $250

SummaryTakara Bio Inc Takara, a subsidiary of Takara Holdings Inc, is a biotechnology company that develops, manufactures and distributes biotechnology research reagents and equipments for life sciences research. The company sells gene amplification system and offers scientific instruments. It offers clinical development of gene therapies for cancer treatment. Takara develops and commercializes me...

Eunice Kennedy Shriver National Institute of Child Health and Human Development Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12102018] Prices from USD $250

SummaryEunice Kennedy Shriver National Institute of Child Health and Human Development NICHD, a subsidiary of National Institutes of Health, is a research institute that conducts and supports laboratory research, clinical trials, and epidemiological studies. The institute conducts research in the fields of fields of reducing infant deaths, improving health of women, men and families learning. It o...

Healogics Provides Unrestricted Educational Grant to Support an American Diabetes Association Compendium: Diagnosis and Management of Diabetic Foot Complications

Healogics Inc., the nation’s largest provider of advanced wound care services, today announced their support of the American Diabetes Association (ADA) Compendium Diagnosis and Management of Diabetic Foot Ulcer Complications through an unrestricted educational grant1. More

Ology Bioservices Strengthens Management Team with Addition of Timothy Cooke, Ph.D. as Senior Vice President of Commercial Business

Ology Bioservices, Inc., a biologics contract development and manufacturing organization (CDMO), announced today that industry veteran Timothy Cooke, Ph.D., has joined the Company as Senior Vice President of Commercial Business. “Tim brings to Ology Bioservices more than 25 years of experience in the development of vaccines and immunotherapeutic...

ATyr Pharma Chief Scientific Officer, David King, to Resign

ATyr Pharma, a developer of protein drugs, said Monday its chief scientific officer will leave the company at year’s end. David King has been with San Diego, CA-based aTyr (NASDAQ: LIFE) for two years. He is resigning to start a biotech company, aTyr said in a prepared statement, which quoted King as saying that launching […]

Aldevron Honored by Goldman Sachs for Entrepreneurship

Michael Chambers, Founder and CEO, Among 100 Most Intriguing Entrepreneurs at 2018 Builders + Innovators Summit Goldman Sachs (NYSE:GS) is recognizing Aldevron CEO and Founder Michael Chambers as one of the 100 Most Intriguing Entrepreneurs at the 2018 Builders + Innovators Summit in Santa Barbara, California. This press release features multimedia. Vie...

Archived chat: Nobel laureate James Allison looks to the future of cancer immunotherapy

When James Allison began studying whether the immune system's T cells could be tweaked to attack tumors, merely entertaining the notion was a good way to sink your scientific career:…

Live chat at 11:30 a.m. ET: Nobel laureate James Allison looks to the future of cancer immunotherapy

When James Allison began studying whether the immune system's T cells could be tweaked to attack tumors, merely entertaining the notion was a good way to sink your scientific career:…

Lynn Winterton, Ph.D., Pioneering Contact Lens Inventor, Named to OcuMedic, Inc. Scientific Advisory Board

Winterton’s patented contact lenses generate over $2 billion in annual revenue OcuMedic, Inc., the developer of new, drug-eluting soft contact lens and clear corneal bandage technology, today announced the appointment of Lynn Winterton, Ph.D., as a key member of its Scientific Advisory Board. He also has taken an ownership position with the co...

Biedermann Motech to Launch MDS Injection Screw for its Polyaxial Humerus Plating Systems

Biedermann Motech, the leading innovator of polyaxial screw technologies, announced today the launch of the first injection screw that can be used through, and in combination with, its polyaxial locking plate systems at the 2018 Orthopaedic Trauma Association (OTA) Annual Meeting in Kissimmee (Orlando), October 17-20, 2018. This press release features multi...

Immusoft Receives Rare Pediatric Disease Designation for Treatment of MPS I

Company seeks to use engineered B cells to deliver missing enzyme for patients Immusoft Corporation, a Seattle-Wash.-based cell therapy company, announced today that the U.S. Food and Drug Administration (FDA) has granted it Rare Pediatric Disease Designation (RPDD) for Iduronicrin genleukocel-T, Immusoft’s Sleeping Beauty transposon-engineered ...

Alicia Kali Named Finalist in 15th Annual Stevie® Awards for Women in Business

Stevie Award Winners to Be Announced in New York on November 16 WOODBURY, Minn. (PRWEB) October 17, 2018 Alicia Kali—Founder of the non-profit organization Purpose DRV'N as well as Founder and Chief Scientific Officer of Panacea Biomed—was named a Finalist in the Woman of the Year category in the 15th annual Stevie® Awards for Women in Business, and will ultimately be a Gold, Silver,...

DNAnexus Granted Authority to Operate by Health and Human Services (HHS) for FedRAMP Moderate

Government agencies can now easily integrate biomedical data management and informatics into their research and services. DNAnexus Inc. announced today it has been granted an Authority to Operate (ATO) under the Federal Risk and Authorization Management Program (FedRAMP) for the management and analysis of biomedical data on its cloud-b...

EVIO Canada’s Keystone Labs Invests in Significant Expansion and Upgrades

Ready to meet testing demands for Cannabis Legalization EVIO Inc. (“EVIO” or the “Company”), (OTCQB: EVIO), a leading provider of cannabis testing and scientific research for the regulated cannabis industry, announced that EVIO Canada’s Keystone Labs in Edmonton invested $1,100,000 in facility expansion and new equipment upgrades to pr...

John Amatruda, MD, and Philip Lambert, PhD, Join Life Biosciences

Widely Accomplished Executives Will Focus on Eight Pathways of Aging Through Life Laboratories and Drug Discovery Life Biosciences Inc. announced today the appointment of two renowned scientists to senior positions at the pioneering company. Dr. John Amatruda has been appointed president of Life Laboratories, which provides central management...

Avidity Biosciences Receives Investment from CureDuchenne

Investment advances pre-clinical development of novel exon skipping therapies for treatment of patients with Duchenne muscular dystrophy Avidity Biosciences, a privately held biotech company pioneering a new class of precision medicines based upon antibody-oligonucleotide conjugates, announced today that CureDuchenne has made an equity investment in th...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks